El Diario Montañés

Alerta

ConSalud

Within the call Valdecilla Biosanitary Promotion Program 2018, IDIVAL launches the intensification program.

This programme (Int-Val) release clinical practitioners with heavy research and/or innovation workloads from their other duties. IDIVAL funds the part-time or full-time substitution of doctors or nurses involved in research or innovation projects. The activity covered by this substitution includes the development of research projects, or the implementation of assistance innovation programs such as new diagnostic or therapeutic techniques, implementation of technological platforms (computer programs, new infrastructures), new procedures, import of technology, new training techniques, development of companies linked to research (spin-offs), etc., which require intensive dedication and are incompatible with full care work.

The program has two modalities:

Modality A. Competitive intensification. Funded by this program.

Modality B. Autointensification. Funded by private funds contributed by the researchers.

Modalitiy A is open until April 15.

Link to the grant: http://www.idival.org/es/Portal-de-Ayudas

The following session of the program of lectures Valdecilla Progress Reports will take place on April 11 and it will be given by María Iglesias, Dept. of Autoimmunity and Trasplantation, and María Carcelen, group of cytokines and growth factors pathological tissue plasticity phenomena at the Instituto de Investigación Valdecilla (IDIVAL), who will present their scientific advances of their current projects.

Speaker: María Iglesias

Session: Utility of myeloid-derived suppressor cells (MDSC) in monitoring renal transplant patients.

María Iglesias Escudero is PhD student, Dept. of Autoimmunity and Trasplantation, Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain. 

In 2016 she finished the period of training for specialists in Immunology and she obtained the Immunology Specialist qualification (Hospital Universitario Central de Asturias, Spain). During this four-year training period she complemented daily clinical practice with research work, participating in projects within department lines of study: transplant, coronary pathology immune aging and arthropathies immune aging. As Immunology resident, she decided to increase her training in the area of Histocompatibility and Transplantation. She had also previously trained in the area of Histocompatibility and Transplantation in 2011 in the Dept. of Immunology-Genetics, Hospital Universitario Infanta Cristina de Badajoz, Spain. She is currently developing her activity as a predoctoral researcher at IDIVAL.

Speaker: María Carcelen

Session: MicroRNAs and neuropathic pain

María Carcelen Labrador is a PhD student in the group of cytokines and growth factors pathological tissue plasticity phenomena at the Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain. 

She gained her degree in Health Biology at the Universidad de Alcalá in Madrid in 2015. Then she studied a Master of Microbiology at the Universidad Autónoma de Madrid. Since then, she is training in different techniques and subjects like molecular biology, microscopies, etc. She is currently developing her activity as a predoctoral researcher at IDIVAL.
Each speaker will talk about 15 minutes followed by a small debate and at the end, coffee will be served to continue the conversation and encourage interaction between participants and attendees.

The meeting will take place on April 11, in lecture room 4-5, pavilion 16 of the HUMV (1^st floor) and has a capacity of 30 people. 

Researchers who attend 80% of the meetings throughout the academic year will receive a certificate of assistance.

For any questions regarding Progress Reports sessions, please contact the department at gesval1@idival.org

Acta Sanitaria

El Diario Montañés

Europa Press

El diario.es

El diario Montañés

UNICAN

Europa Press

La Vanguardia

El diario Montañés

Europa Press

Acta Sanitaria

IDIVAL launches the second programme of sessions Valdecilla Progress Report as part of its talent development and knowledge exchange program. In this program, young researchers from the clinical field and IDIVAL's laboratories present scientific advances in their current research projects. These sessions are intended to encourage discussion and networking among the researchers and doctors and to add value to the work being carried out. Speakers will be predoctoral contracts, researchers Post-MIR Valdecilla López Albo, etc. They will present these sessions with the presence of their corresponding project directors.

This year all the sessions will be monthly and will have two speakers who will present their progress and lines of work. Each speaker will talk about 15 minutes followed by a small debate and at the end, coffee will be served to continue the conversation and encourage interaction between participants and attendees.

All sessions will take place at 2:00 pm in Pavilion 16 of the Marqués de Valdecilla University Hospital (maximum capacity of 30 people). In addition, certificates of attendance will be issued if 80% of the sessions are attended throughout the academic period, and participation in them will be taken into account within the doctoral program.

On November 15, the first session will be given by David San Segundo Arribas, a specialist in Immunology and member of the IDIVAL research group on Autoimmunity and Transplantation, who will talk about “Myeloid-derived suppressor cells (MDSC) and immunoregulation in transplantation” and María Juncal Ruíz, child psychiatrist at Sierrallana Hospital and researcher in the program of first episodes of psychosis (PAFIP) of the University Hospital Marqués de Valdecilla and PhD student at the University of Cantabria, which will focus its session on the “systemic immunoinflammatory response in patients with a first psychotic episode”.

We encourage all the researchers and young specialists to attend on Wednesday, November 15 at 2:00 p.m. in room 2-3 of Hall 16 HUMV.